Navigation Links
Joslin researcher named first winner of the Manpei Suzuki International Prize for Diabetes Research

BOSTON November 6, 2008 Joslin Diabetes Center today announced that C. Ronald Kahn, M.D., Head of the Joslin Section on Obesity and Hormone Action and the Mary K. Iacocca Professor of Medicine at Harvard Medical School, has been named the first winner of the Manpei Suzuki International Prize for Diabetes Research.

"Joslin Diabetes Center is delighted that one of our world-renowned researchers has been named the inaugural winner of such a prestigious award," said Ranch C. Kimball, President and CEO of Joslin. "Dr. Kahn epitomizes the spirit, perseverance and creativity held by all Joslin researchers that is needed to make the scientific advancements toward preventing and ultimately curing diabetes."

According to the Manpei Suzuki Diabetes Foundation, Dr. Kahn was selected to receive the inaugural award in recognition of his many contributions to diabetes research over the past three decades from the discovery of the basic mechanism for how insulin receptors produce a signal in cells to increase their metabolism, to alterations in this signaling process in diabetes and other disease states. He has also generated multiple strains of mice genetically altered in insulin signaling in order to analyze insulin action one tissue and pathway at a time. Dr. Kahn's work has had an enormous impact on the understanding of the mechanism of insulin action and insulin resistance, processes that are fundamental to the worldwide diabetes epidemic.

"I am truly honored to be recognized for this prize as my lab and I to continue to pursue new frontiers in diabetes and obesity research," said Dr. Kahn.

Dr. Kahn will be formally presented with the award, which includes $150,000, at a ceremony in Tokyo on March 10, 2009. He will also deliver a commemorative lecture at the event.

The newly established award, the largest for diabetes research and one of the largest in medicine, commemorates the 15th anniversary of the Manpei Suzuki Diabetes Foundation, which supports diabetes research through both grants and fellowships. According to the Foundation's web site, the International Prize acknowledges individuals for "their original and excellent achievements in diabetes research" and aims "to advance diabetes research that will contribute to the health and welfare of all people."

An internationally recognized researcher, Dr. Kahn was educated at University of Louisville and trained at Washington University and the National Institutes of Health, where he ultimately served as the Section Head of Cellular and Molecular Physiology of the Diabetes Branch.

In 1981, Dr. Kahn came to Harvard Medical School and the Joslin Diabetes Center. He served as Research Director of Joslin from 1981 to 2000, Executive Vice President from 1997 to 2000, and President and Director from 2000 to 2007. In 1984, he was promoted to Professor of Medicine at Harvard, and in 1986 he was awarded the Mary K. Iacocca Professorship. In 2007, he was named Vice Chair of the Joslin Board of Trustees.

Dr. Kahn has received the highest scientific awards of the American Diabetes Association, U.S. Endocrine Society, British Diabetes and Endocrine Societies, Juvenile Diabetes Research Foundation, International Diabetes Federation and American Federation for Clinical Research, as well as many other honors, including election to the National Academy of Sciences and the Institute of Medicine. He chaired the congressionally established Diabetes Research Working Group which developed the plan that resulted in a more than doubling of diabetes research efforts in the U.S. He also holds honorary doctorates from the Universities of Paris, Louisville and Geneva and an honorary professorship from Peking University.


Contact: Kira Jastive
Joslin Diabetes Center

Related medicine news :

1. Joslin study finds restricting insulin doses increases mortality risk
2. Researchers describe how chronic inflammation can lead to stomach cancer
3. Researchers ID Genetic Markers for Esophageal Cancer
4. Opt out system could solve donor organ shortage, says researcher
5. Researchers identify mechanism, possible drug treatment for tumors in neurofibromatosis
6. Cancer requires support from immune system to develop, UT Southwestern researchers report
7. Researchers find new chemical key that could unlock hundreds of new antibiotics
8. Penn researchers find key to Sonic hedgehog control of brain development
9. Temple researchers look for behavioral link between breastfeeding and lower risk of obesity
10. MU researchers advance health communication for at-risk populations
11. Researcher to provide new insight for treating vascular disease
Post Your Comments:
(Date:11/29/2015)... ... 2015 , ... Effective immediately, every single IguanaMed scrub style will be available ... is offering a “Buy One Scrub Set, Get the 2nd Scrub Set 50% Off” ... at a discounted price. , IguanaMed’s mission is to outfit every healer ...
(Date:11/28/2015)... ... November 28, 2015 , ... Safe storage for contraceptive devices may not ... from Lakewood, New Jersey and the other from Bradley Beach, New Jersey, there is ... the expense of having to replace NuvaRings more often than necessary. As such, it ...
(Date:11/28/2015)... ... 2015 , ... Pixel Film Studios is back again with ProPanel: Pulse ... are endless. Users have full control over angle of view, speed method, start point, ... sure to get heads to turn. , ProPanel: Pulse offers fully customizable pulsating shape ...
(Date:11/27/2015)... ... 2015 , ... According to an article published November 6th by ... University of British Columbia suggested that laws requiring bicyclists to wear helmets may not ... of the reason for the controversial conclusion is that, while helmets have certainly prevented ...
(Date:11/27/2015)... , ... November 27, 2015 , ... A team of ... ways to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Hospital Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , 26 november 2015 AAIPharma ... de geplande investering aan van ten minste ... laboratoria en het mondiale hoofdkantoor in ... zal resulteren in extra kantoorruimte en extra ... de groeiende behoeften van de farmaceutische en ...
(Date:11/26/2015)... 2015 Research and Markets ( ) has ... Market Outlook to 2019 - Rise in Cardiac Disorders and ... report to their offering. Boston ... scientific and others. --> The ... Boston scientific and others. ...
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... Global Cell Surface Testing Market: Supplier ... to their offering.  --> ... of the  "2016 Future Horizons and ...
Breaking Medicine Technology: